121 related articles for article (PubMed ID: 1728853)
21. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
Starz H; Balda BR; Bachter D; Büchels H; Vogt H
Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
[TBL] [Abstract][Full Text] [Related]
22. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
23. Light microscopic, S-100 immunostaining, and ultrastructural analysis of dermatopathic lymphadenopathy, with and without associated mycosis fungoides.
Herrera GA
Am J Clin Pathol; 1987 Feb; 87(2):187-95. PubMed ID: 3544800
[TBL] [Abstract][Full Text] [Related]
24. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
26. Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides.
Burke JS; Colby TV
Am J Surg Pathol; 1981 Jun; 5(4):343-52. PubMed ID: 7270782
[TBL] [Abstract][Full Text] [Related]
27. Lymphography in the assessment of mycosis fungoides.
Tallroth K; Wiljasalo M; Valle M; Korhola O
Lymphology; 1977 Sep; 10(3):147-50. PubMed ID: 592885
[TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
[TBL] [Abstract][Full Text] [Related]
29. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
Scheffer E; Meijer CJ; Van Vloten WA
Cancer; 1980 Jan; 45(1):137-48. PubMed ID: 7350998
[TBL] [Abstract][Full Text] [Related]
30. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
31. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
32. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
33. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
35. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
Hödl S
Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
[TBL] [Abstract][Full Text] [Related]
36. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
37. Early detection of cutaneous lymphoma.
Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
[TBL] [Abstract][Full Text] [Related]
38. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
39. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics.
Botros N; Cerroni L; Shawwa A; Green PJ; Greer W; Pasternak S; Walsh NM
Am J Dermatopathol; 2015 Apr; 37(4):274-83. PubMed ID: 25794369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
